ADCs

With over ten years of experience supporting (ADC) discovery, development, and manufacturing, our multidisciplinary team has worked with a range of different antibodies, linkers and toxins to enable us to develop customised bioconjugation approaches and offer complex ADC solutions to our customers.

All articles

One pager2 min read

Measurement of ADC stability in plasma via released payload quantitation Read more

ADCs

News1 min read

Sterling recognised in best CRO category at World ADC Awards Read more

Infographic1 min read

[Infographic] Destroying Cancerous Cells Read more

Infographic1 min read

[Infographic] Optimising ADCs through three critical components Read more

Antibody Drug Conjugate ADC

Infographic1 min read

Harnessing magic bullets to outsmart cancer Read more

Stewart Mitchell, site head at ADC facility in Deeside, Wales, UK

News2 min read

Sterling appoints Stewart Mitchell as site head for its ADC facility Read more

Preview of antibody drug conjugates (ADCs) - The magic bullets animation

Animation2 min read

Antibody drug conjugates (ADC): The magic bullets Read more

Sterling's Antibody Drug Conjugate (ADC) facility in Deeside, Wales, UK

News2 min read

FDA approves ADC supported by Sterling Read more

News2 min read

Sterling Pharma Solutions acquires ADC Bio Read more

Explore more

All ADCs API Development API Manufacturing Analytical Services Drug Discovery Facilities News PDMO People Peptides Sustainability Technologies

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

LinkedIn

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229